185 related articles for article (PubMed ID: 22840351)
41. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
[TBL] [Abstract][Full Text] [Related]
42. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
43. Oncological and Functional Outcomes for Men Undergoing Salvage Whole-gland Cryoablation for Radiation-resistant Prostate Cancer.
Tan WP; Kotamarti S; Ayala A; Mahle R; Chen E; Arcot R; Chang A; Michael Z; Seguier D; Polascik TJ
Eur Urol Oncol; 2023 Jun; 6(3):289-294. PubMed ID: 36890104
[TBL] [Abstract][Full Text] [Related]
44. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
45. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
[TBL] [Abstract][Full Text] [Related]
46. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G
Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039
[TBL] [Abstract][Full Text] [Related]
47. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
48. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer.
Lambert EH; Bolte K; Masson P; Katz AE
Urology; 2007 Jun; 69(6):1117-20. PubMed ID: 17572198
[TBL] [Abstract][Full Text] [Related]
49. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
[TBL] [Abstract][Full Text] [Related]
50. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
51. Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results.
Lohm G; Bottke D; Jamil B; Miller K; Neumann K; Bartkowiak D; Hinkelbein W; Wiegel T
World J Urol; 2013 Apr; 31(2):423-8. PubMed ID: 22460203
[TBL] [Abstract][Full Text] [Related]
52. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications.
Chin JL; Pautler SE; Mouraviev V; Touma N; Moore K; Downey DB
J Urol; 2001 Jun; 165(6 Pt 1):1937-41; discussion 1941-2. PubMed ID: 11371885
[TBL] [Abstract][Full Text] [Related]
53. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
[TBL] [Abstract][Full Text] [Related]
54. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
[TBL] [Abstract][Full Text] [Related]
55. Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy.
Yoo S; You D; Kim YS; Hong JH; Ahn H; Kim CS
Urol Int; 2017; 99(4):406-413. PubMed ID: 29020683
[TBL] [Abstract][Full Text] [Related]
56. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
[TBL] [Abstract][Full Text] [Related]
57. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients.
Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A
Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165
[TBL] [Abstract][Full Text] [Related]
58. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.
Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL
Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783
[TBL] [Abstract][Full Text] [Related]
59. Early Endpoints in High-risk Localized Prostate Cancer: Exploratory Analysis of Three Radiation Therapy Oncology Group Phase 3 Studies.
Feng F; Miladinovic B; Zhang K; Dignam JJ; Wang D; Yu M; Sandler H
Eur Urol; 2023 Sep; 84(3):331-340. PubMed ID: 37393115
[TBL] [Abstract][Full Text] [Related]
60. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy.
Lian H; Yang R; Lin T; Wang W; Zhang G; Guo H
Int Urol Nephrol; 2016 Sep; 48(9):1461-6. PubMed ID: 27300004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]